Skip to main content
Caplight Logo









Novogaia

Novogaia

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.novogaia.bio/

Last Round

Seed

Jan 1, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Novogaia is a biotechnology company that develops new medicines from fungi using artificial intelligence to decode drug-like molecular structures.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, ML Platforms, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Foundation

Keywords

AI drug discoveryAI biotechnatural product discoverydrug discovery platformfungal-derived therapeuticsfoundation modelfrontier AI labin silico drug discoverygenerative biologymolecular structure predictionmass spectrometryautoimmunity therapeuticscomp biometabologenomicspharmaceutical partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novogaia Comparables

Compare Novogaia with similar companies based on industry and business-model similarity.

Novogaia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kapoose Creek Bio
83%
LifeMine Therapeutics
79%
Simplicia, Inc.
78%

Novogaia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 1, 2026

Key People

Founding team and executive leadership

Tess Bevers

Co-founder & CEO

Founding Team

Novogaia Investors

Notable investors and investment history

Novogaia investors
InvestorRounds
Backed VCSeed
Entrepreneurs FirstAccelerator, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 587% MoM, reaching 2.4K.

  • Jan 1, 2026

    Raised a seed round with Backed VC and Entrepreneurs First.

Novogaia Filings

Explore SEC and related filing metadata, where available.

Novogaia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Novogaia's valuation, stock price, and market status.

Is Novogaia a public or private company?

Novogaia is a private company.

What is the current stock price of Novogaia?

Novogaia is a private company with no public stock price. No recent secondary market data is available.

How much is Novogaia worth (valuation)?

Valuation information for Novogaia is not publicly available.

Can I buy Novogaia stock?

Novogaia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Novogaia's last funding round?

Novogaia's most recent funding round was Seed on January 1, 2026.

Who are the main investors in Novogaia?

Key investors in Novogaia include Backed VC, Entrepreneurs First.

Will Novogaia IPO soon?

No public IPO plans have been announced for Novogaia.

How can I track Novogaia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novogaia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range6
Year Founded2024
Last FundingJan 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?